A Study of NE3107 in Early Parkinson's

NCT06757010 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinsons Disease (PD)

Interventions

DRUG: NE3107
DRUG: Placebo

Sponsor

BioVie Inc.